Liver resection is superior to tumor ablation in patients with multifocal hepatocellular carcinoma,Journal of Surgical Oncology

当前位置： X-MOL 学术 › J. Surg. Oncol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Liver resection is superior to tumor ablation in patients with multifocal hepatocellular carcinoma
Journal of Surgical Oncology ( IF 2.5 ) Pub Date : 2024-02-09 , DOI: 10.1002/jso.27599
Hanna Kakish ₁ , Mohammed O. Suraju ₂ , Erik S. Davis ₂ , Abhinav Seth ₂ , Yong K. Kwon ₃ , Hassan Aziz ₂

Affiliation

The management of T2 multifocal hepatocellular carcinoma (MHCC) is controversial, and the comparative impact of liver resection (LR) versus tumor ablation (TA) on survival continues to be debated. The aim of our study was to examine short- and long-term survival for LR and TA in a nationally representative cohort. We hypothesized that patients who underwent LR would have improved survival.

更新日期：2024-02-09

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>